Cargando…
(20S)G-Rh2 Inhibits NF-κB Regulated Epithelial-Mesenchymal Transition by Targeting Annexin A2
(1) Background: Epithelial-mesenchymal transition (EMT) is an essential step for cancer metastasis; targeting EMT is an important path for cancer treatment and drug development. NF-κB, an important transcription factor, has been shown to be responsible for cancer metastasis by enhancing the EMT proc...
Autores principales: | Wang, Yu-Shi, Li, He, Li, Yang, Zhang, Shiyin, Jin, Ying-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225922/ https://www.ncbi.nlm.nih.gov/pubmed/32244350 http://dx.doi.org/10.3390/biom10040528 |
Ejemplares similares
-
(20S) Ginsenoside Rh2 Inhibits STAT3/VEGF Signaling by Targeting Annexin A2
por: Wang, Yu-Shi, et al.
Publicado: (2021) -
Epithelial‐Mesenchymal Transition in colorectal cancer: Annexin A2 is caught in the crosshairs
por: ROCHA, Murilo Ramos, et al.
Publicado: (2021) -
20(S)-ginsenoside Rh2 as agent for the treatment of LMN-CRC via regulating epithelial–mesenchymal transition
por: Yuan, Yihang, et al.
Publicado: (2020) -
HLJ2 Effectively Ameliorates Colitis-Associated Cancer via Inhibition of NF-κB and Epithelial–Mesenchymal Transition
por: Song, Huachen, et al.
Publicado: (2020) -
Annexin A2 Silencing Inhibits Proliferation and Epithelial-to-mesenchymal Transition through p53-Dependent Pathway in NSCLCs
por: Wu, Minhua, et al.
Publicado: (2019)